内皮调节因子V的原血栓表型 莱登:来自活体模型的证据
Nadine Schwarz1, Jens Müller1, Hannah L McRae1
1Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Germany.
Arteriosclerosis, thrombosis, and vascular biology
|January 23, 2025
概括
无症状携带因子V莱登 (FVL) 突变的携带者由于内皮细胞而表现出更高的激活蛋白C (APC) 反应,与有静脉血栓塞栓症 (VTE) 史的人不同. 这表明内皮在FVL血栓性中起着作用.
科学领域:
- 血液学 血液学 血液学
- 血栓形成的原因是血栓形成.
- 血管生物学 血管生物学
背景情况:
- 因子V莱登 (FVL) 突变的临床影响在个体之间有很大差异.
- 之前的研究表明,与有静脉血栓栓塞 (VTE) 病史的人相比,无症状的FVL携带者具有更高的激活蛋白C (APC) 反应.
研究的目的:
- 使用ex vivo模型调查FVL突变,APC反应和VTE史之间的关联.
- 探索患者特异性内皮细胞在调节FVL载体APC反应中的作用.
主要方法:
- 一个使用患者衍生的内皮细胞形成细胞 (ECFC) 和来自FVL携带者 (有或没有VTE病史) 和对照者的血的ex vivo模型.
- 测量血栓和APC生成,APC抑制动力学和内皮细胞表面受体表达 (TM,EPCR).
主要成果:
- 在没有VTE病史的FVL携带者中观察到显著更高的APC响应 (APC/血AUC),而在使用自身ECFC时,与具有VTE病史的人相比.
- 交叉实验证实,来自VTE个体的FVLECFC增强了APC反应,无论血来源如何.
- 两组之间在APC抑制剂水平,APC无活化动力学,APC灵敏度比率或TM/EPCR表达方面没有发现显著差异.
结论:
- 血中FVL突变的APC耐药性表型相似,但内皮细胞依赖的APC响应率显著不同.
- 无症状的FVL携带者表现出更高的内皮APC反应,这表明内皮具有调节疾病的作用.
- 需要进一步的研究,以了解内皮质影响FVL血栓友的分子机制.
关键词:
它们的内皮质 (endothelium).蛋白 C 是一种蛋白质.血栓激素 血栓激素 是一种血栓友爱症 (Thrombophilia) 是一种发生血栓友爱的疾病.静脉血栓塞栓症是一种静脉血栓塞栓.更多相关视频
08:30Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
11.2K
06:27A Novel In vitro Model for Studying the Interactions Between Human Whole Blood and Endothelium
Published on: November 21, 2014
9.4K
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
603
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
603
01:20Extrinsic and Intrinsic Pathways of Hemostasis
5.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.1K